Keyphrases
Denmark
100%
Confidence Interval
65%
Type 1 Diabetes Mellitus (T1DM)
61%
Type I Diabetes
50%
National Cohort Study
47%
COVID-19
38%
Hypoglycemia
32%
Type 2 Diabetes Mellitus (T2DM)
28%
Randomized Controlled Trial
28%
Hazard Ratio
27%
Heart Failure
26%
Out-of-hospital Cardiac Arrest
25%
Risk Factors
24%
All-cause Mortality
20%
Inflammatory Bowel Disease
20%
Odds Ratio
19%
Atrial Fibrillation
18%
Placebo
18%
Diabetes
17%
Type 2 Diabetic Patients
17%
Hospitalization
17%
Severe Hypoglycemia
17%
Myocardial Infarction
16%
Intensive Care Unit
16%
Randomized Clinical Trial
16%
Incidence Rate
16%
Comorbidity
15%
High Risk
14%
Chronic Obstructive Pulmonary Disease
14%
Hemoglobin A1c (HbA1c)
13%
Prospective Cohort Study
13%
Meta-analysis
12%
Nationwide Registry
12%
Quality of Life
12%
Register Study
12%
Health-related Quality of Life
11%
Randomized Placebo-controlled Trial
11%
Community-acquired Pneumonia
11%
Systematic Meta-analysis
11%
AIMS™
10%
Hospitalized Patients
10%
Respiratory Syncytial Virus
10%
Chronic Kidney Disease
10%
Copenhagen
10%
Cardiovascular Risk
10%
Insulin
10%
Patients with Diabetes
10%
Intensive Care Unit Patients
10%
Cardiovascular Disease
9%
Pregnant Women
9%
Retrospective Cohort Study
9%
Continuous Glucose Monitoring
9%
Cardiovascular Mortality
9%
Nationwide Registers
9%
Randomized Trial
9%
Hospital Admission
9%
Colorectal Cancer
8%
Crohn's Disease
8%
Venous Thromboembolism
8%
Ulcerative Colitis
8%
Anesthesia
8%
Mortality Risk
8%
Europe
8%
Septic Shock
8%
Adult Patients
8%
Population-based Study
8%
Physical Activity
8%
Population-based Cohort Study
7%
30-day Mortality
7%
Infective Endocarditis
7%
Acute Coronary Syndrome
7%
Without Diabetes
7%
Clinical Practice
7%
COVID-19 Pandemic
7%
Non-associated
7%
During Pregnancy
7%
Blood Samples
7%
Patients with COVID-19
6%
Body Mass Index
6%
Population-based
6%
Danish Population
6%
Cardiovascular Events
6%
Registry-based
6%
Relative Risk
6%
Intensive Care
6%
Prospective Observational Study
6%
Capital Region
6%
Computed Tomography
6%
Observational Cohort Study
6%
Healthcare Professionals
6%
Dialysis
6%
Gestational Age
6%
Adverse Events
6%
Absolute Risk
6%
Liraglutide
6%
Healthy Individuals
6%
Critically Ill Patients
6%
Ischemic Stroke
6%
Acute Myocardial Infarction
6%
Emergency Department
5%
Medicine and Dentistry
Cohort Analysis
78%
COVID-19
32%
Infection
30%
Randomized Controlled Trial
28%
Diabetes
26%
Disease
25%
Symptom
25%
Insulin Dependent Diabetes Mellitus
23%
Heart Failure
23%
Intensive Care Unit
20%
Hazard Ratio
20%
Cardiovascular System
20%
Systematic Review
19%
Maturity Onset Diabetes of the Young
19%
Out of Hospital Cardiac Arrest
19%
Hypoglycemia
18%
Placebo
18%
Quality of Life
18%
Prevalence
17%
Severe Acute Respiratory Syndrome Coronavirus 2
17%
Diagnosis
15%
Odds Ratio
15%
Randomized Clinical Trial
15%
Atrial Fibrillation
15%
Inflammatory Bowel Disease
13%
Chronic Obstructive Pulmonary Disease
13%
Apoplexy
13%
Cardiovascular Disease
12%
Biological Marker
12%
Prospective Cohort Study
12%
Malignant Neoplasm
12%
Meta-Analysis
12%
Patient with Type 2 Diabetes
12%
Observational Study
11%
Hemoglobin A1c
11%
Surgery
11%
Cesarean Section
10%
Myocardial Infarction
10%
Triage
10%
Adverse Event
10%
All Cause Mortality
10%
Community-Acquired Pneumonia
9%
Outpatient
9%
Antibiotics
8%
Intensive Care
8%
Retrospective Cohort Study
8%
Body Mass Index
8%
Proportional Hazards Model
8%
Logistic Regression Analysis
8%
Childbirth
8%
Chronic Kidney Disease
7%
Computer Assisted Tomography
7%
Human Immunodeficiency Virus
7%
Bleeding
7%
Venous Thromboembolism
7%
Diabetes Mellitus
7%
Drug Therapy
7%
Coronary Artery Disease
7%
Resuscitation
7%
Acute Coronary Syndrome
7%
Recurrent Disease
7%
Pediatrics
7%
First Trimester Pregnancy
7%
Ulcerative Colitis
7%
Adolescent
7%
Health Care
7%
Obstetrics
7%
Injury
6%
Colorectal Cancer
6%
Septic Shock
6%
Crohn's Disease
6%
Cohort Study
6%
Health Care Cost
6%
Volunteer
6%
Clinical Trial
6%
Colon Cancer
6%
Population
6%
Antibiotic Therapy
6%
Neoplasm
6%
Clinician
6%
Mortality Rate
6%
Emergency Department
5%
Coronary Angiography
5%
Infective Endocarditis
5%
Magnetic Resonance Imaging
5%
Physical Activity
5%
Child
5%
Low Drug Dose
5%
Cross Sectional Study
5%
Blood Pressure
5%
Case-Control Study
5%
Arm
5%
Sepsis
5%
Combination Therapy
5%
Human Respiratory Syncytial Virus
5%
Airway Management
5%
Cardiovascular Risk
5%
Hormone Therapy
5%
Patient with Type 1 Diabetes
5%
Heart Arrest
5%